Diabetes in Asia and the pacific: Implications for the global epidemic

Diabetes Care

Volumn 39, Issue 3, 2016, Pages 472-485

  Nanditha, Arun ^a   Ma, Ronald C W ^b,c   Ramachandran, Ambady ^a   Snehalatha, Chamukuttan ^a   Chan, Juliana C N ^b,c   Chia, Kee Seng ^d   Shaw, Jonathan E ^e   Zimmet, Paul Z ^e  

^a India Diabetes Research Foundation   (India)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASIA; AUSTRALIA; DEMOGRAPHY; DEVELOPING COUNTRY; DISEASE SURVEILLANCE; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; EPIGENETICS; ETHNICITY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HEREDITY; HUMAN; LIFESTYLE MODIFICATION; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PACIFIC ISLANDS; PATHOGENESIS; PREGNANCY DIABETES MELLITUS; PREVALENCE; PREVENTIVE MEDICINE; RURAL AREA; SOCIAL STATUS; URBAN AREA; URBANIZATION; AUSTRALIA AND NEW ZEALAND; DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ASIA; AUSTRALASIA; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 2; EPIDEMICS; GLOBAL HEALTH; HUMANS; RISK FACTORS;

EID: 84962045551     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1536     Document Type: Article

References (115)

1. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2014;2:56-64
2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103:137-149
3. Chan JC, Cho NH, Tajima N, Shaw J. Diabetes in the Western Pacific Region-past, present and future. Diabetes Res Clin Pract 2014;103:244-255
4. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophys-iology. JAMA 2009;301:2129-2140
5. Ramachandran A, Snehalatha C, Ma RC. Diabetes in South-East Asia: an update. Diabetes Res Clin Pract 2014;103:231-237
6. Ramachandran A, Ma RCW, Snehalatha C. Diabetes in Asia. Lancet 2010;375:408-418
7. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61-73
8. Chan JCN, Yeung R, Luk A. The Asian diabetes phenotypes: challenges and opportunities. Diabetes Res Clin Pract 2014;105:135-139
9. Tutino GE, Tam WH, Yang X, Chan JC, Lao TT, Ma RC. Diabetes and pregnancy: perspectives from Asia. Diabet Med 2014;31:302-318
10. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium, International Diabetes Federation, 2013. Available from www .idf.org/diabetesatlas. Accessed 31 March 2014
11. World Health Organization. STEPS country reports [Internet]. Available from http://www .who.int/chp/steps/reports/en/. Accessed 31 March 2014
12. Sherwin RS, Anderson RM, Buse JB, et al.; American Diabetes Association. The prevention or delay of type 2 diabetes. Diabetes Care 2003; 26(Suppl. 1):S62-S69
13. Misra A, Ramchandran A, Jayawardena R, Shrivastava U, Snehalatha C. Diabetes in South Asians. Diabet Med 2014;31:1153-1162
14. Tin ST, Lee CM, Colagiuri R. A profile of diabetes in Pacific Island Countries and Territories. Diabetes Res Clin Pract 2015;107:233-246
15. Xu Y, Wang L, He J, et al.; 2010 China Non-communicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-959
16. King H, Keuky L, Seng S, Khun T, Roglic G, Pinget M. Diabetes and associated disorders in Cambodia: two epidemiological surveys. Lancet 2005;366:1633-1639
17. Morimoto A, Nishimura R, Tajima N. Trends in the epidemiology of patients with diabetes in Japan. Japan Med Assoc J 2010;53:36-40
18. Adam FM, Adam JM, Pandeleki N, Mappangara I. Asymptomatic diabetes: the difference between population-based and office-based screening. Acta Med Indones 2006;38:67-71
19. Mihardja L, Delima, Manz HS, Ghani L, Soegondo S. Prevalence and determinants of diabetes mellitus and impaired glucose tolerance in Indonesia (a part of basic health re-search/Riskesdas). Acta Med Indones 2009;41: 169-174
20. Australian Bureau of Statistics. Australian Health Survey: Biomedical results for chronic diseases, 2011-12 [article online]. Available from http://www.abs.gov.au/AUSSTATS/abs@ .nsf/DetailsPage/4364.0.55.0052011-12. Accessed 31 March 2015
21. Ministry of Health Brunei Darussalam. Health Information Booklet 2010. Bandar Seri Begawan, Brunei Darussalam, 2010. Available from http://www.moh.gov.bn/SiteCollectionDocuments/Health%20Indicator%20Booklet/HIB-2010.pdf. Accessed 12 April 2015
22. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes 2012;3:110-117
23. Siu SC, Wong KW, Lee KF, et al. Prevalence of undiagnosed diabetes mellitus and cardiovascular risk factors in Hong Kong professional drivers. Diabetes Res Clin Pract 2012;96: 60-67
24. University of Health Sciences and the Preventive Medicine Department of the Ministry of Health, Kingdom of Cambodia. Prevalence of Non-Communicable Disease Risk Factors in Cambodia. World Health Organization STEPS Survey, Country Report. World Health Organization, Geneva, Switzerland, September 2010. Available from http://www.who.int/chp/steps/2010-STEPS-Report-Cambodia.pdf. Accessed 12 April 2015
25. Hu D, Sun L, Fu P, et al. Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: the InterASIA Study. Diabetes Res Clin Pract 2009;84:288-295
26. Wan Nazaimoon WM, Md Isa SH, Wan Mohamad WB, et al. Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion. Diabet Med 2013;30:825-828
27. World Health Organization. Mongolian STEPS Survey on the Prevalence of Noncommunicable Disease and Injury Risk Factors-2009. World Health Organization, Geneva, Switzerland, 2010. Available from http://www.who.int/chp/steps/2009-STEPS-Report-Mongolia.pdf?ua=1. Accessed 31 January 2014
28. Coppell KJ, Mann JI, Williams SM, et al. Prevalence of diagnosed and undiagnosed diabetes and prediabetes in New Zealand: findings from the 2008/09 Adult Nutrition Survey. N Z Med J 2013;126:23-42
29. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011;35:303-308
30. Hwang J, Shon C. Relationship between so-cioeconomic status and type 2 diabetes: results from Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012. BMJ Open 2014;4:e005710
31. Singapore MinistryofHealth. Disease Burden. Diabetes prevalence in Singapore [Internet], 2015. Available from https://www.moh.gov.sg/content/moh-web/home/statistics/Health-Facts-Singapore/Disease-Burden.html. Accessed 12 April 2015
32. Deerochanawong C, Ferrario A. Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Global Health 2013;9:11
33. Aekplakorn W, Chariyalertsak S, Kessomboon P, et al.; Thai National Health Examination Survey IV Study Group. Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009. Diabetes Care 2011;34:1980-1985
34. Quang Binh T, Tran Phuong P, Thi Nhung B, et al. Prevalence and correlates of hyperglyce-mia in a rural population, Vietnam: implications from a cross-sectional study. BMC Public Health 2012;12:939
35. Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology-from West to the rest. Diabetes Care 1992;15:232-252
36. Prior IA, Davidson F. The epidemiology of diabetes in Polynesians and Europeans in New Zealand and the Pacific. N Z Med J 1966;65:375-383
37. Zimmet P, Taft P, Guinea A, Guthrie W, Thoma K. The high prevalence of diabetes mel-litus on a Central Pacific Island. Diabetologia 1977;13:111-115
38. Zimmet P, Dowse G, Finch C, Serjeantson S, King H. The epidemiology and natural history of NIDDM-lessons from the South Pacific. Diabetes Metab Rev 1990;6:91-124
39. Collins VR, Dowse GK, Toelupe PM, et al. Increasing prevalence of NIDDM in the Pacific island population of Western Samoa over a 13-year period. Diabetes Care 1994;17:288-296
40. Colagiuri S, Colagiuri R, Na'ati S, Muimuiheata S, Hussain Z, Palu T. The prevalence of diabetes in the kingdom of Tonga. Diabetes Care 2002;25:1378-1383
41. Feisul MI, Azmi S, Ed. National Diabetes Registry Report, Volume 1, 2009-2012 [Internet], 2013.
42. Kuala Lumpur, Ministry of Health Malaysia. Available from http://www.moh.gov.my. Accessed 31 March 2015
43. Saeed KM. Prevalence of risk factors for non-communicable diseases in the adult population of urban areas in Kabul City, Afghanistan. Cent Asian J Glob Health 2013;14:386
44. Akter S, Rahman MM, Abe SK, Sultana P. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bull World Health Organ 2014;92:204-213, 213A
45. Giri BR, Sharma KP, Chapagai RN, Palzom D. Diabetes and hypertension in urban Bhutanese men and women. Indian J Community Med 2013;38:138-143
46. Ramachandran A, Snehalatha C, Kapur A, et al.; Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001;44: 1094-1101
47. Anjana RM, Pradeepa R, Deepa M, et al.; ICMR-INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-3027
48. Aboobakur M, Latheef A, Mohamed AJ, et al. Surveillance for non-communicable disease risk factors in Maldives: results from the first STEPS survey in Male. Int J Public Health 2010;55:489-496
49. Magliano DJ, Söderberg S, Zimmet PZ, et al. Explaining the increase of diabetes prevalence and plasma glucose in Mauritius. Diabetes Care 2012;35:87-91
50. Sharma SK, Ghimire A, Radhakrishnan J, et al. Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens 2011;2011:821971
51. Shera AS, Jawad F, Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract 2007;76:219-222
52. Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP. Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health 2012;25;12:380
53. Anjana RM, Shanthi Rani CS, Deepa M, et al. Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 2015;38:1441-1448
54. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008;31:893-898
55. Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013;1281:64-91
56. Hwang CK, Han PV, Zabetian A, Ali MK, Narayan KM. Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis. Diabetes Res Clin Pract 2012; 96:271-285
57. Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 2011;34:353-357
58. King GL, McNeely MJ, Thorpe LE, et al. Understanding and addressing unique needs of diabetes in Asian Americans, native Hawaiians, and Pacific Islanders. Diabetes Care 2012;35: 1181-1188
59. Karter AJ, Schillinger D, Adams AS, et al. Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE). Diabetes Care 2013;36:574-579
60. Kanaya AM, Herrington D, Vittinghoff E, et al. Understanding the high prevalence of diabetes in U.S. south Asians compared with four racial/ethnic groups: the MASALA and MESA studies. Diabetes Care 2014;37:1621-1628
61. Bhopal R, Unwin N, White M, et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ 1999;319:215-220
62. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011; 34:1249-1257
63. Ma RC, Lin X, Jia W. Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol 2014;2:980-991
64. Misra A, Khurana L, Isharwal S, Bhardwaj S. South Asian diets and insulin resistance. Br J Nutr 2009;101:465-473
65. Hu EA, Pan A, Malik V, Sun Q. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. BMJ 2012;344: e1454
66. Mohan V, Radhika G, Sathya RM, Tamil SR, Ganesan A, Sudha V. Dietary carbohydrates, gly-caemic load, food groups and newly detected type 2 diabetes among urban Asian Indian population in Chennai, India (Chennai Urban Rural Epidemiology Study 59). Br J Nutr 2009;102: 1498-1506
67. Henry CJ, Lightowler HJ, Newens K, et al. Glycaemic index of common foods tested in the UK and India. Br J Nutr 2008;99:840-845
68. Ng SW, Howard AG, Wang HJ, Su C, Zhang B. The physical activity transition among adults in China: 1991-2011. Obes Rev 2014;15(Suppl. 1): 27-36
69. Nyamdorj R, Pitkäniemi J, Tuomilehto J, et al.; DECODA and DECODE Study Groups. Ethnic comparison of the association of undiag-nosed diabetes with obesity. Int J Obes 2010; 34:332-339
70. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 2007;86: 353-359
71. WHO Expert Consultation. Appropriate body mass index for Asian populations and its complications for policy and intervention strategies. Lancet 2004;363:157-163
72. Huxley R, Barzi F, Lee CM, et al.; Obesity in Asia Collaboration. Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes. Diabetes Care 2007;30:3116-3118
73. Cameron AJ, Sicree RA, Zimmet PZ, et al. Cut-points for waist circumference in Europids and South Asians. Obesity (Silver Spring) 2010; 18:2039-2046
74. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phe-notype hypothesis. Diabetologia 1992;35:595-601
75. Ravelli AC, van der Meulen JH, Michels RP, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998;351:173-177
76. Li Y, He Y, Qi L, et al. Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes 2010;59:2400-2406
77. Yajnik CS. Nutrient-mediated teratogenesis and fuel-mediated teratogenesis: two pathways of intrauterine programming of diabetes. Int J Gynaecol Obstet 2009;104(Suppl. 1):S27-S31
78. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes 1988;37:622-628
79. Ma RC, Chan JC, Tam WH, Hanson MA, Gluckman PD. Gestational diabetes, maternal obesity, and the NCD burden. Clin Obstet Gynecol 2013;56:633-641
80. Ma RC, Tutino GE, Lillycrop KA, Hanson MA, Tam WH. Maternal diabetes, gestational diabetes and the role of epigenetics in their long term effects on offspring. Prog Biophys Mol Biol 2015;118:55-68
81. Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014;103:176-185
82. Wong VW. Gestational diabetes mellitus in five ethnic groups: a comparison of their clinical characteristics. Diabet Med 2012;29:366-371
83. Zhang F, Dong L, Zhang CP, et al. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet Med 2011;28:652-657
84. World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. World Health Organization, Geneva, Switzerland, 2013. Available from http://apps.who.int/iris/bitstream/10665/85975/1/WHO-NMH-MND-13.2-eng.pdf. Accessed 20 April 2015
85. Hirst JE, Tran TS, Do MA, Morris JM, Jeffery HE. Consequences of gestational diabetes in an urban hospital in Viet Nam: a prospective cohort study. PLoS Med 2012;9:e1001272
86. Hanson MA, Gluckman PD, Ma RC, Matzen P, Biesma RG. Early life opportunities for prevention of diabetes in low and middle income countries. BMC Public Health 2012;12:1025
87. Hanson MA, Bardsley A, De-Regil LM, et al. The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: "Think Nutrition First." Int J Gynaecol Obstet 2015;131(Suppl. 4):S213
88. Bennett PH, Lee ET, Lu M, Keen H, Fuller JH. Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44(Suppl. 2):S37-S45
89. Kenealy T, Elley CR, Collins JF, Moyes SA, Metcalf PA, Drury PL. Increased prevalence of albuminuria among non-European peoples with type 2 diabetes. Nephrol Dial Transplant 2012; 27:1840-1846
90. Bhalla V, Zhao B, Azar KM, et al. Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care 2013;36:1215-1221
91. Yau JW, Rogers SL, Kawasaki R, et al.; Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-564
92. Tan ED, Davis WA, Davis TM. Changes in characteristics and management of Asian and Anglo-Celts with type 2 diabetes over a 15-year period in an urban Australian community: The Fremantle Diabetes Study. J Diabetes. 12 January 2015 [Epub ahead of print]. DOI: 10.1111/1753-0407.12267
93. Kanaya AM, Adler N, Moffet HH, et al. Heterogeneity of diabetes outcomes among Asians and Pacific Islanders in the US: the Diabetes Study of Northern California (DISTANCE). Diabetes Care 2011;34:930-937
94. Chi ZS, Lee ET, Lu M, Keen H, Bennett PH. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44 (Suppl. 2):S82-S86
95. Clarke PM, Glasziou P, Patel A, et al.; ADVANCE Collaborative Group. Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Med 2010;7:e1000236
96. Yang X, So WY, Kong AP, et al. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am J Car-diol 2008;101:596-601
97. Chaturvedi N, Abbott CA, Whalley A, Widdows P, Leggetter SY, Boulton AJ. Risk of diabetes-related amputation in South Asians vs. Europeans in the UK. Diabet Med 2002;19: 99-104
98. Yeung RO, Zhang Y, Luk A, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol 2014;2:935-943
99. Chan JC, Lau ES, Luk AO, et al. Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis. Am J Med 2014;127:616-624
100. Ramachandran A, Snehalatha C. Diabetes prevention programs. Med Clin North Am 2011;95:353-372, viii
101. Knowler WC, Fowler SE, Hamman RF, et al.; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677-1686
102. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-1350
103. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20: 537-544
104. Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2014;2: 474-480
105. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetolo-gia 2006;49:289-297
106. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005;67:152-162
107. Saito T, Watanabe M, Nishida J, et al.; Zensharen Study for Prevention of Lifestyle Diseases Group. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med 2011;1715: 1352-1360
108. Ramachandran A, Snehalatha C, Shetty SA, Nanditha A. Primary prevention trials in type 2 diabetes. In Global Health Perspectives in Prediabe-tes and Diabetes Prevention. Bergman M, Ed. Singapore, World Scientific Publication, 2014, p. 49-74
109. Ramachandran A, Snehalatha C, Ram J, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 2013;1:191-198
110. Chan JC, Zhang Y, Ning G. Diabetes in China: a societal solution fora personal challenge. Lancet Diabetes Endocrinol 2014;2:969-979
111. Western Pacific Declaration on Diabetes [Internet], 2001. Available from http://www .wpdd.org/. Accessed 20 April 2015
112. Ministryof Health Singapore. National Health Survey 2010 [Internet], 2011. Available from http://www.moh.gov.sg/content/moh-web/home/Publications/Reports/2011/national-health- survey2010.html. Accessed 10 April 2015
113. Phan TP, Alkema L, Tai ES, et al. Forecasting the burden of type 2 diabetes in Singapore using a demographic epidemiological model of Singapore. BMJ Open Diabetes Res Care 2014;2: e000012
114. Ang HS. Singapore's Healthier Hawker Programme. Paper presented at the Culinary Institute of America, 15th Annual Worlds of Flavor Conference, 1-3 November 2012, St. Helena, CA
115. Chia SE, Chia A, Sng J. A total workplace safety and health service - what are the implications for the employees and employers? Ann Acad Med Singapore 2014;43:475-476